Cargando…

Imbalances in Kynurenines as Potential Biomarkers in the Diagnosis and Treatment of Psychiatric Disorders

Detalles Bibliográficos
Autores principales:	Myint, Aye-Mu, Halaris, Angelos
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Psychiatry
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9275364/ https://www.ncbi.nlm.nih.gov/pubmed/35836656 http://dx.doi.org/10.3389/fpsyt.2022.913303

Ejemplares similares

High Kynurenine (a Tryptophan Metabolite) Predicts Remission in Patients with Major Depression to Add-on Treatment with Celecoxib
por: Krause, Daniela, et al.
Publicado: (2017)

Involvement of Kynurenine Metabolism in Bipolar Disorder: An Updated Review
por: Zhang, Peifen, et al.
Publicado: (2021)

Exploring the role of ketone bodies in the diagnosis and treatment of psychiatric disorders
por: Omori, Naomi Elyse, et al.
Publicado: (2023)

The impact of neuroimmune dysregulation on neuroprotection and neurotoxicity in psychiatric disorders - relation to drug treatment
por: Müller, Norbert, et al.
Publicado: (2009)

The Metabolic Factor Kynurenic Acid of Kynurenine Pathway Predicts Major Depressive Disorder
por: Liu, Hongye, et al.
Publicado: (2018)

Detecting Neuroimaging Biomarkers for Psychiatric Disorders: Sample Size Matters
por: Schnack, Hugo G., et al.
Publicado: (2016)

Cytokine Imbalance in Schizophrenia. From Research to Clinic: Potential Implications for Treatment
por: Reale, Marcella, et al.
Publicado: (2021)

Attention-deficit hyperactivity disorder (ADHD) and glial integrity: an exploration of associations of cytokines and kynurenine metabolites with symptoms and attention
por: Oades, Robert D, et al.
Publicado: (2010)

Attention-deficit hyperactivity disorder (ADHD) and glial integrity: S100B, cytokines and kynurenine metabolism - effects of medication
por: Oades, Robert D, et al.
Publicado: (2010)

Kynurenine 3-Monooxygenase: An Influential Mediator of Neuropathology
por: Parrott, Jennifer M., et al.
Publicado: (2015)

Editorial: Efficacy of Psychological and Psychiatric Treatments and Potential Predictors in Social Anxiety Disorder and Obsessive-Compulsive Disorder
por: Pozza, Andrea
Publicado: (2022)

COX-2 Inhibitors, Aspirin, and Other Potential Anti-Inflammatory Treatments for Psychiatric Disorders
por: Müller, Norbert
Publicado: (2019)

Effects of stress associated with academic examination on the kynurenine pathway profile in healthy students
por: Myint, Kyaimon, et al.
Publicado: (2021)

The Scope of Metacognitive Therapy in the Treatment of Psychiatric Disorders
por: Sharma, Vandita, et al.
Publicado: (2022)

Virtual Reality Objectifies the Diagnosis of Psychiatric Disorders: A Literature Review
por: van Bennekom, Martine J., et al.
Publicado: (2017)

A Potential Interface between the Kynurenine Pathway and Autonomic Imbalance in Schizophrenia
por: Büki, Alexandra, et al.
Publicado: (2021)

Editorial: Psychiatric comorbidities in patients with epilepsy: diagnosis and treatment
por: Oddo, Silvia, et al.
Publicado: (2023)

Vitamin D status in children with a psychiatric diagnosis, autism spectrum disorders, or internalizing disorders
por: Muskens, Jet, et al.
Publicado: (2022)

Editorial: Dual disorders (addictive and concomitant psychiatric disorders): Mechanisms and treatment
por: Vorspan, Florence, et al.
Publicado: (2022)

Therapeutic Potential of Exogenous Ketone Supplement Induced Ketosis in the Treatment of Psychiatric Disorders: Review of Current Literature
por: Kovács, Zsolt, et al.
Publicado: (2019)

Changes of Altruistic Behavior and Kynurenine Pathway in Late-Life Depression
por: Wu, Yujie, et al.
Publicado: (2020)

Autism Spectrum Disorders and Schizophrenia Spectrum Disorders: Excitation/Inhibition Imbalance and Developmental Trajectories
por: Canitano, Roberto, et al.
Publicado: (2017)

Editorial: Cognition Across the Psychiatric Disorder Spectrum: From Mental Health to Clinical Diagnosis
por: Gurvich, Caroline, et al.
Publicado: (2015)

Cardiolipin Antibody: A Potential Biomarker for Depression
por: Costa, Renzo, et al.
Publicado: (2022)

Editorial: Psychiatric Disorder in Veterans
por: Pasinetti, Giulio M., et al.
Publicado: (2021)

Kynurenine pathway metabolites are associated with gray matter volume in subjects with schizophrenia
por: Zhou, Sumiao, et al.
Publicado: (2022)

The Impact of Alexithymia on Treatment Response in Psychiatric Disorders: A Systematic Review
por: Pinna, Federica, et al.
Publicado: (2020)

Police Encounters, Agitation, Diagnosis, and Employment Predict Psychiatric Hospitalisation of Intensive Home Treatment Patients During a Psychiatric Crisis
por: Barakat, Ansam, et al.
Publicado: (2021)

Editorial: Neuroinflammation, metabolism, and psychiatric disorders
por: Freyberg, Zachary, et al.
Publicado: (2022)

Connectomic Intermediate Phenotypes for Psychiatric Disorders
por: Fornito, Alex, et al.
Publicado: (2012)

Recognizing Psychiatric Comorbidity With Reading Disorders
por: Hendren, Robert L., et al.
Publicado: (2018)

Emerging Roles of Complement in Psychiatric Disorders
por: Druart, Mélanie, et al.
Publicado: (2019)

Editorial: Cognitive Enhancement in Psychiatric Disorders
por: Sumiyoshi, Tomiki, et al.
Publicado: (2019)

Prospects for the Use of Cannabinoids in Psychiatric Disorders
por: Graczyk, Michał, et al.
Publicado: (2021)

Editorial: Cardiometabolic disease and psychiatric disorders
por: Deste, Giacomo, et al.
Publicado: (2023)

Editorial: Neurocognitive deficits in psychiatric disorders
por: Yang, Jie
Publicado: (2023)

L-Carnitine and Acetyl-L-Carnitine: Potential Novel Biomarkers for Major Depressive Disorder
por: Nie, Li-Juan, et al.
Publicado: (2021)

Commentary: Clinical Approach to the Differential Diagnosis between Behavioral Variant Frontotemporal Dementia and Primary Psychiatric Disorders
por: Jha, Manish Kumar, et al.
Publicado: (2016)

Use of Gabapentin in the Treatment of Substance Use and Psychiatric Disorders: A Systematic Review
por: Ahmed, Saeed, et al.
Publicado: (2019)

Editorial: Appropriateness and safety of using cannabinoid and psychedelic medicines as treatments for psychiatric disorders
por: Blest-Hopley, Grace, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_o10sul36d7qti6nnvmqqjflbmj